174 related articles for article (PubMed ID: 36387060)
1. Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.
Franco-Paredes C; Garcia-Creighton E; Henao-Martínez A; Kallgren DL; Banjade R; Dyer JA; Nelson T; Zaesim A; Peluso MJ; Jain V; Lee DH; Minces LR; Wirshup M; Sierra Hoffman M; Katsolis J; Brust K; Giron J; Smiarowski L; Hoosepian-Mer PA; Stryjewska B
Ther Adv Infect Dis; 2022; 9():20499361221135885. PubMed ID: 36387060
[TBL] [Abstract][Full Text] [Related]
2. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
Legendre DP; Muzny CA; Swiatlo E
Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.
Faust L; Klowak M; MacRae C; Kopalakrishnan S; Showler AJ; Boggild AK
J Cutan Med Surg; 2021; 25(1):45-52. PubMed ID: 32869655
[TBL] [Abstract][Full Text] [Related]
5. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
6. Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.
Labuda SM; Schieffelin JS; Shaffer JG; Stryjewska BM
Am J Trop Med Hyg; 2017 Dec; 97(6):1726-1730. PubMed ID: 29141716
[TBL] [Abstract][Full Text] [Related]
7. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
Medeiros S; Catorze MG; Vieira MR
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
[TBL] [Abstract][Full Text] [Related]
8. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
9. [Guideline for the treatment of Hansen's disease in Japan (Second edition)].
Goto M; Nogami R; Hatano K; Okano Y; Ishii N; Gidoh M; Ishida Y; Ozaki M;
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):191-226. PubMed ID: 17037376
[TBL] [Abstract][Full Text] [Related]
10. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of multi-drug therapy for leprosy in the United States using daily rifampin.
Dacso MM; Jacobson RR; Scollard DM; Stryjewska BM; Prestigiacomo JF
South Med J; 2011 Oct; 104(10):689-94. PubMed ID: 21941157
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil.
Maia MV; Cunha Mda G; Cunha CS
An Bras Dermatol; 2013; 88(2):205-10. PubMed ID: 23739719
[TBL] [Abstract][Full Text] [Related]
13. [Guideline for the treatment of Hansen's disease in Japan].
Goto M; Ishida Y; Gidoh M; Nagao E; Namisato M; Ishii N; Ozaki M;
Nihon Hansenbyo Gakkai Zasshi; 2000 Nov; 69(3):157-77. PubMed ID: 11187723
[TBL] [Abstract][Full Text] [Related]
14. Treatment of leprosy/Hansen's disease in the early 21st century.
Worobec SM
Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
[TBL] [Abstract][Full Text] [Related]
15. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
[TBL] [Abstract][Full Text] [Related]
16. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Histopathological Response to Multidrug Therapy in Paucibacillary Leprosy at the end of 6 Months: A Prospective Observational Study from Eastern India.
Podder I; Saha A; Bandyopadhyay D
Indian J Dermatol; 2018; 63(1):47-52. PubMed ID: 29527025
[TBL] [Abstract][Full Text] [Related]
18. Comparison between lymecycline with multidrug therapy and standard multidrug regimen (WHO-MDT) in the treatment of multibacillary leprosy patients: a retrospective cohort study.
Diaz JCD; Abad-Venida ML; Espinoza-Thaebtharm A; Cathryn Salonga ME; Abad-Casintahan MF
Int J Dermatol; 2023 Sep; 62(9):1186-1192. PubMed ID: 37408116
[TBL] [Abstract][Full Text] [Related]
19. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M
Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118
[TBL] [Abstract][Full Text] [Related]
20. Resolution of type 1 reaction in multibacillary Hansen's disease as a result of treatment with cyclosporine.
Frankel RI; Mita RT; Kim R; Dann FJ
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):8-12. PubMed ID: 1602196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
